BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1510137)

  • 1. Glibenclamide decreases basal coronary blood flow in anesthetized dogs.
    Imamura Y; Tomoike H; Narishige T; Takahashi T; Kasuya H; Takeshita A
    Am J Physiol; 1992 Aug; 263(2 Pt 2):H399-404. PubMed ID: 1510137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous adenosine mediates coronary vasodilation during exercise after K(ATP)+ channel blockade.
    Duncker DJ; van Zon NS; Pavek TJ; Herrlinger SK; Bache RJ
    J Clin Invest; 1995 Jan; 95(1):285-95. PubMed ID: 7814627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glibenclamide prevents coronary vasodilation induced by beta 1-adrenoceptor stimulation in dogs.
    Narishige T; Egashira K; Akatsuka Y; Imamura Y; Takahashi T; Kasuya H; Takeshita A
    Am J Physiol; 1994 Jan; 266(1 Pt 2):H84-92. PubMed ID: 7905717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of K+ATP channels in coronary vasodilation during exercise.
    Duncker DJ; Van Zon NS; Altman JD; Pavek TJ; Bache RJ
    Circulation; 1993 Sep; 88(3):1245-53. PubMed ID: 8353886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of K+ ATP channels and adenosine in the regulation of coronary blood flow during exercise with normal and restricted coronary blood flow.
    Duncker DJ; van Zon NS; Ishibashi Y; Bache RJ
    J Clin Invest; 1996 Feb; 97(4):996-1009. PubMed ID: 8613554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glibenclamide enhances but pinacidil reduces attenuation in sympathetic responsiveness after acute coronary artery occlusion.
    Ito M; Pride HP; Zipes DP
    Circ Res; 1994 Aug; 75(2):379-92. PubMed ID: 8033347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of adenosine triphosphate-sensitive potassium channels eliminates isoflurane-induced coronary artery vasodilation.
    Cason BA; Shubayev I; Hickey RF
    Anesthesiology; 1994 Nov; 81(5):1245-55; discussion 27A-28A. PubMed ID: 7978484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of ATP-sensitive K+ channel on ECG ST segment elevation during a bout of myocardial ischemia. A study on epicardial mapping in dogs.
    Kubota I; Yamaki M; Shibata T; Ikeno E; Hosoya Y; Tomoike H
    Circulation; 1993 Oct; 88(4 Pt 1):1845-51. PubMed ID: 8403330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATP sensitive potassium channels are involved in adenosine A2 receptor mediated coronary vasodilatation in the dog.
    Akatsuka Y; Egashira K; Katsuda Y; Narishige T; Ueno H; Shimokawa H; Takeshita A
    Cardiovasc Res; 1994 Jun; 28(6):906-11. PubMed ID: 7923297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of activation of ATP-dependent potassium channels with (-)-pinacidil and (-)-3-pyridyl pinacidil on infarct size in a canine model of ischemia-reperfusion injury.
    Smallwood JK; Schelm JA; Bemis KG; Simpson PJ
    J Cardiovasc Pharmacol; 1993 Nov; 22(5):731-43. PubMed ID: 7506326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATP-sensitive K+ channel opener pinacidil augments beta 1-adrenoceptor-induced coronary vasodilation in dogs.
    Katsuda Y; Egashira K; Ueno H; Arai Y; Akatsuka Y; Kuga T; Shimokawa H; Takeshita A
    Am J Physiol; 1996 Jun; 270(6 Pt 2):H2210-5. PubMed ID: 8764276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine triphosphate-sensitive K+ channels mediate postcardioplegia coronary hyperemia.
    Wang SY; Friedman M; Johnson RG; Zeind AJ; Sellke FW
    J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 1):1073-82. PubMed ID: 7475136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glibenclamide, a putative ATP-sensitive K+ channel blocker, inhibits coronary autoregulation in anesthetized dogs.
    Narishige T; Egashira K; Akatsuka Y; Katsuda Y; Numaguchi K; Sakata M; Takeshita A
    Circ Res; 1993 Oct; 73(4):771-6. PubMed ID: 8370126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glibenclamide, a selective inhibitor of ATP-sensitive K+ channels, attenuates metabolic coronary vasodilatation induced by pacing tachycardia in dogs.
    Katsuda Y; Egashira K; Ueno H; Akatsuka Y; Narishige T; Arai Y; Takayanagi T; Shimokawa H; Takeshita A
    Circulation; 1995 Aug; 92(3):511-7. PubMed ID: 7634466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of K+ATP channels in local metabolic coronary vasodilation.
    Richmond KN; Tune JD; Gorman MW; Feigl EO
    Am J Physiol; 1999 Dec; 277(6):H2115-23. PubMed ID: 10600828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cromakalim and pinacidil on large epicardial and small coronary arteries in conscious dogs.
    Giudicelli JF; la Rochelle CD; Berdeaux A
    J Pharmacol Exp Ther; 1990 Nov; 255(2):836-42. PubMed ID: 2173761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary vascular K+ATP channels contribute to the maintenance of myocardial perfusion in dogs with pacing-induced heart failure.
    Yamamoto M; Egashira K; Arimura K; Tada H; Shimokawa H; Takeshita A
    Jpn Circ J; 2000 Sep; 64(9):701-7. PubMed ID: 10981856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glibenclamide, a specific inhibitor of ATP-sensitive K+ channels, inhibits coronary vasodilation induced by angiotensin II-receptor antagonists.
    Tada H; Egashira K; Yamamoto M; Ueno H; Takemoto M; Shimokawa H; Takeshita A
    J Cardiovasc Pharmacol; 1997 Sep; 30(3):313-9. PubMed ID: 9300314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemic cardioprotection by ATP-sensitive K+ channels involves high-energy phosphate preservation.
    McPherson CD; Pierce GN; Cole WC
    Am J Physiol; 1993 Nov; 265(5 Pt 2):H1809-18. PubMed ID: 8238595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of blockade of the ATP-sensitive potassium channel on metabolic coronary vasodilation in the dog.
    Aversano T; Ouyang P; Silverman H; Ziegelstein RC; Gips S
    Pharmacology; 1993 Dec; 47(6):360-8. PubMed ID: 8278458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.